psicose, (d)-isomer has been researched along with Inflammation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Banno, R; Cheng, M; Gou, Y; Iida, T; Koike, T; Liu, B; Wang, S; Yamada, T | 1 |
Bae, HR; Han, Y; Kim, S; Kwon, EY; Shin, SK; Yoo, JH; Young, HA | 1 |
Choi, MS; Han, Y; Kwon, EY | 1 |
Dong, Y; Hirata, Y; Hirose, K; Hossain, A; Kamitori, K; Katagi, A; Matsunaga, T; Noguchi, C; Sui, L; Tokuda, M; Tsukamoto, I; Yamaguchi, F | 1 |
4 other study(ies) available for psicose, (d)-isomer and Inflammation
Article | Year |
---|---|
d-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats.
Topics: Animals; Cytokines; Diet, High-Fat; Fructose; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Phosphorylation; Rats; Rats, Wistar; Signal Transduction | 2021 |
D-Allulose Ameliorates Dysregulated Macrophage Function and Mitochondrial NADH Homeostasis, Mitigating Obesity-Induced Insulin Resistance.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Homeostasis; Humans; Inflammation; Insulin Resistance; Insulins; Macrophages; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Obesity | 2023 |
Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Fructose; Gastrointestinal Microbiome; Glucose; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Obesity; Phytotherapy; RNA, Messenger | 2020 |
Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
Topics: Abdominal Fat; Adiposity; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Fructose; Glycated Hemoglobin; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Rats, Inbred OLETF; Time Factors; Weight Gain | 2015 |